Suppr超能文献

耐烷化剂的人类肿瘤细胞系的开发。

Development of alkylating agent-resistant human tumor cell lines.

作者信息

Teicher B A, Frei E

机构信息

Dana-Farber Cancer Institute, Boston, MA 02115.

出版信息

Cancer Chemother Pharmacol. 1988;21(4):292-8. doi: 10.1007/BF00264194.

Abstract

Survival curves and dose escalation studies of four representative human tumor cell lines exposed to the various alkylating agents are presented. With HN2, at a level of one log of cell kill there was a fivefold range in drug concentration required to achieve this degree of cell kill among the cell lines, from 4.5 microM for the SL6 lung adenocarcinoma to 22 microM for the SW2 small-cell lung carcinoma. Four logs of SCC-25 squamous carcinoma cells were killed by 100 microM CDDP; however, there was only about one log of SL6 cells killed by 500 microM CDDP. To kill one log of G3361 melanoma cells required 24 microM 4-HC and to kill one log of SCC-25 cells required 24 microM, approximately a 16-fold difference. The curves for cell kill by L-PAM appeared to be biphasic, with a break at about 100 microM. There was about a threefold range in drug concentration required to achieve one log of cell kill with L-PAM, from 60 microM in the SCC-25 cell line to 18 microM in the SW2 line. To kill one log of SCC-25 cells required 295 microM BCNU and to kill one log of SW2 cell required 120 microM, about a 2.5-fold difference. The range of maximally tolerated HN2 concentrations were from 1200 microM for the SL6 cell line, 48 times the initial concentration, to 300 microM for the SCC-25 line, 16 times the initial concentration. The G3361 line tolerated the highest level of CDDP, 1900 microM, 48 times the initial concentration. The SCC-25 line, on the other hand, tolerated only 600 microM, 30 times the initial concentration. The SL6 cell line maximally tolerated 36 times the initial concentration of 4-HC (1450 microM), whereas the SCC-25 cell line tolerated only 18 times the initial concentration (720 microM). The G3361 melanoma tolerated 1555 microM, 30 times the initial concentration of L-PAM, and the SCC-25 cell line tolerated 700 microM, 14 times the initial concentration. The SL6 cell line tolerated the highest concentration of BCNU, 4200 microM, 24 times the initial concentration. The SCC-25 cell line tolerated 1450 microM, 8 times the initial concentration. In all cases, the SCC-25 cell line was least able to tolerate exposure to increasing concentrations of alkylating agents. The SL6 and G3361 cell lines showed the greatest tolerance for increasing concentrations of alkylating agents.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

本文展示了四种具有代表性的人类肿瘤细胞系在暴露于各种烷化剂后的生存曲线和剂量递增研究。对于HN2,在细胞杀伤达到一个对数水平时,各细胞系实现该程度细胞杀伤所需的药物浓度范围为五倍,从SL6肺腺癌的4.5微摩尔/升至SW2小细胞肺癌的22微摩尔/升。100微摩尔/升的顺铂可杀死四个对数的SCC - 25鳞状癌细胞;然而,500微摩尔/升的顺铂只能杀死约一个对数的SL6细胞。杀死一个对数的G3361黑色素瘤细胞需要24微摩尔/升的4 - HC,而杀死一个对数的SCC - 25细胞需要24微摩尔/升,两者相差约16倍。左旋苯丙氨酸氮芥(L - PAM)的细胞杀伤曲线似乎呈双相,在约100微摩尔/升处有一个转折点。使用L - PAM实现一个对数的细胞杀伤所需的药物浓度范围约为三倍,从SCC - 25细胞系的60微摩尔/升至SW2细胞系的18微摩尔/升。杀死一个对数的SCC - 25细胞需要295微摩尔/升的卡氮芥(BCNU),而杀死一个对数的SW2细胞需要120微摩尔/升,相差约2.5倍。最大耐受的HN2浓度范围为:SL6细胞系为1200微摩尔/升,是初始浓度的48倍;SCC - 25细胞系为300微摩尔/升,是初始浓度的16倍。G3361细胞系对顺铂的耐受水平最高,为1900微摩尔/升,是初始浓度的48倍。另一方面,SCC - 25细胞系仅耐受600微摩尔/升,是初始浓度的30倍。SL6细胞系对4 - HC的最大耐受浓度为初始浓度的36倍(1450微摩尔/升),而SCC - 25细胞系仅耐受初始浓度的18倍(720微摩尔/升)。G3361黑色素瘤对L - PAM的耐受浓度为1555微摩尔/升,是初始浓度的30倍,SCC - 25细胞系耐受700微摩尔/升,是初始浓度的14倍。SL6细胞系对BCNU的耐受浓度最高,为4200微摩尔/升,是初始浓度的24倍。SCC - 25细胞系耐受1450微摩尔/升,是初始浓度的8倍。在所有情况下,SCC - 25细胞系最不能耐受暴露于不断增加浓度的烷化剂。SL6和G3361细胞系对不断增加浓度的烷化剂表现出最大的耐受性。(摘要截取自400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验